September 22, 2018
1 min read

Rutgers Cancer Institute of New Jersey names breast surgery chief

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Photo of Michele Blackwood 2018
M. Michele Blackwood

M. Michele Blackwood, MD, FACS, has been named chief of breast surgery at Rutgers Cancer Institute.

Blackwood will work with the surgical team at the institute’s Stacy Goldstein Breast Cancer Center to expand and enhance surgical and clinical services.

Blackwood — who specializes in surgical treatment of complex breast malignancies — most recently served as medical director and northern regional director of breast services for RWJBarnabas Health, a partner of Rutgers Cancer Institute.

“As New Jersey’s only National Cancer Institute-designated comprehensive cancer center, it is our mission to provide the most advanced, world-class cancer care close to home. The expanded role of Dr. Blackwood to our team demonstrates our commitment to provide integrated breast cancer services across RWJBarnabas Health and Rutgers Cancer Institute so that we can ensure our collective reach touches every part of our state,” Steven K. Libutti, MD, FACS, director of Rutgers Cancer Institute and senior vice president of oncology services for RWJBarnabas Health, said in a press release.

Blackwood is a fellow of the American College of Surgeons and is certified by the American Board of Surgery. She also is participating in the Harvard Medical School for Surgical Leadership Program.

“Breast cancer is a complex disease with multiple causes, types and treatment options,” Blackwood said in the release. “I ensure that my patients are provided with the necessary information about their diagnosis, their genetics and their treatment options. ... My dual roles across both Rutgers Cancer Institute and RWJBarnabas Health enable me to ensure that [patients with breast cancer] do not have to travel far for state-of-the-art cancer care.”